Corporate Council

Corporate Council Members

  • The image shows the logo of Amgen, featuring the word "AMGEN" in bold blue letters with a modern, sans-serif font against a white background.
  • Logo of Aquestive Therapeutics featuring a stylized circular design in shades of blue followed by the name "Aquestive" in bold black lettering on a white background.
  • Logo of ARS Pharma featuring a stylized blue geometric shape with a green triangular element on the left and the words "ARS Pharma" in blue and green text on the right.
  • Logo of AstraZeneca featuring a stylized yellow emblem above the name "AstraZeneca" in purple text.
  • Logo of Blueprint Medicine featuring the company name in a bold, modern font. A stylized DNA strand forms part of the letter "b," incorporating shades of blue.
  • Logo of Bryn Pharma featuring a stylized blue medical cross with diagonal lines resembling wings, followed by the text "Bryn" in bold dark blue and "Pharma" in smaller light blue font.
  • The image shows the Chiesi logo, featuring a stylized hexagonal shape with an arrow and dot in pink, next to the text "Chiesi" in bold black letters.
  • Logo featuring two concentric circles above a curved line, resembling sound waves, with the text "dbv technologies" below in lowercase letters. The design uses shades of blue and gray on a white background.
  • The image shows the Genentech logo, featuring the word "Genentech" in blue, stylized, bold font on a white background.
  • Orange emblem with "gsk" in white lowercase letters, above the name "GlaxoSmithKline" in gray.
  • Logo of Incyte featuring the name in blue text with two overlapping circles, one in light blue and the other in green, partially encircling the text.
  • The image shows the word "kaléo" in lowercase letters. The logo features a stylized design with a small triangle over the letter 'e' and a geometric shape incorporated into the letter 'k'.
  • Logo of Novartis featuring a stylized orange and yellow flame design with a vertical blue element at the center above the brand name "Novartis" in blue capital letters.
  • Logos of two companies: "sanofi" in black with purple dots on the "s" and "i," and "REGENERON" in blue, below the sanofi logo.
  • Viatris logo featuring a stylized globe with purple and yellow swoosh-like arcs next to the company name written in bold, dark blue letters.

Allergy & Asthma Network’s Corporate Council is a critical collaboration between the organization and high-level industry and partner leaders. The Corporate Council is focused on advancing Allergy & Asthma Network’s mission and values as well as mutual, appropriate goals of improving health outcomes. Grounded in transparency and innovation, membership in Corporate Council demonstrates partnership and a shared commitment to improve the lives and health of people with allergies, asthma and related conditions.

Members of Corporate Council convene annually to:

  • Receive updates on key priorities, goals and impact across the organization’s mission pillars.
  • Explore strategies to educate, advocate and advance research and health equity.
  • Discuss key issues among Council members and Network leadership that can be addressed collectively.

In addition to the annual meeting, Corporate Council members communicate with Allergy & Asthma Network’s leadership team throughout the year to:

  • Discuss key issues and their implications, such as access issues and guidelines-based care.
  • Create a better value proposition for both partners.
  • Discuss partnership opportunities that arise during the year
  • Gain insights from the patient perspective.
  • Discuss key advocacy issues and trends.

Corporate Council members are acknowledged every year at the annual meeting, the USAsthma Summit and Allergy & Asthma Day on Capitol Hill.

For more information on how to become a member of our Corporate Council, please contact Lynda Mitchell, CEO.